Literature DB >> 19463763

Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of fracture and need for parathyroidectomy in CKD.

David Goldsmith1, Prajesh Kothawala, Arpi Chalian, Myriam Bernal, Sean Robbins, Adrian Covic.   

Abstract

BACKGROUND: Chronic kidney disease (CKD) is associated with such complications as fractures and the need for parathyroidectomy. Mineral metabolism control in patients with CKD has been poor. Studies have assessed fractures and parathyroidectomy risk with mineral disturbances, but with considerable diversity in methods. Thus, a systematic review was conducted to assess method or clinical heterogeneity by comparing the design, analytical techniques, and results of studies. STUDY
DESIGN: Systematic review of the MEDLINE, EMBASE, and Cochrane databases between 1980 and December 2007. SETTING & POPULATION: Patients with CKD or dialysis patients. SELECTION CRITERIA FOR STUDIES: Observational and clinical trials investigating the risk of fractures or parathyroidectomy with mineral disturbances. PREDICTOR: Mineral metabolism variables (phosphorus, calcium, and parathyroid hormone [PTH] levels). OUTCOMES: Fractures, need for parathyroidectomy.
RESULTS: 9 studies were identified that assessed fractures (n = 6) or need for parathyroidectomy (n = 3). Data for fractures or parathyroidectomy risk in predialysis patients are absent. Diversity across studies was observed in populations, methods of exposure assessment, adjusted covariates, and reference mineral levels used in risk estimation. A significant fracture risk was observed with increasing PTH levels. However, additional data are required to understand fracture risk with changes in phosphorus or calcium levels. Data supported greater parathyroidectomy risk with increasing PTH, phosphorus, or calcium levels. LIMITATIONS: Clinical and method heterogeneity across studies precluding the quantitative synthesis of data.
CONCLUSIONS: Serious limitations were observed in the number, quality, and method rigor of studies. Despite heterogeneity across studies, data suggest a significant parathyroidectomy risk with mineral disturbances and a fracture risk with increasing PTH levels in dialysis patients. Additional high-quality data for risk of fractures or parathyroidectomy with changes in phosphorus, calcium, or PTH levels is required to highlight the importance of managing such common, but subclinical, conditions as mineral metabolism disturbances.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19463763     DOI: 10.1053/j.ajkd.2009.02.010

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  10 in total

Review 1.  Mineral metabolism and vitamin D in chronic kidney disease--more questions than answers.

Authors:  David J A Goldsmith; John Cunningham
Journal:  Nat Rev Nephrol       Date:  2011-05-03       Impact factor: 28.314

2.  Increased risk of hip fracture among Japanese hemodialysis patients.

Authors:  Minako Wakasugi; Junichiro James Kazama; Masatomo Taniguchi; Atsushi Wada; Kunitoshi Iseki; Yoshiharu Tsubakihara; Ichiei Narita
Journal:  J Bone Miner Metab       Date:  2013-01-06       Impact factor: 2.626

3.  Economic evaluation of cinacalcet in the treatment of secondary hyperparathyroidism in Italy.

Authors:  Mario Eandi; Lorenzo Pradelli; Sergio Iannazzo; Silvia Chiroli; Giuseppe Pontoriero
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

4.  Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial.

Authors:  Sharon M Moe; Safa Abdalla; Glenn M Chertow; Patrick S Parfrey; Geoffrey A Block; Ricardo Correa-Rotter; Jürgen Floege; Charles A Herzog; Gerard M London; Kenneth W Mahaffey; David C Wheeler; Bastian Dehmel; William G Goodman; Tilman B Drüeke
Journal:  J Am Soc Nephrol       Date:  2014-12-11       Impact factor: 10.121

5.  Prevalence of Hyperparathyroidism, Mineral and Bone Disorders in Children with Advanced Chronic Kidney Disease.

Authors:  Sherif El Desoky; Youssef M K Farag; Eatidal Safdar; Mohamed Ahmed Shalaby; Ajay K Singh; Jameela A Kari
Journal:  Indian J Pediatr       Date:  2016-01-30       Impact factor: 1.967

6.  (18)F-fluoride positron emission tomography measurements of regional bone formation in hemodialysis patients with suspected adynamic bone disease.

Authors:  Michelle L Frost; Juliet E Compston; David Goldsmith; Amelia E Moore; Glen M Blake; Musib Siddique; Linda Skingle; Ignac Fogelman
Journal:  Calcif Tissue Int       Date:  2013-08-31       Impact factor: 4.333

7.  The Effect of Parathyroidectomy on Risk of Hip Fracture in Secondary Hyperparathyroidism.

Authors:  Elin Isaksson; Kerstin Ivarsson; Shahriar Akaberi; Andreas Muth; Gunnar Sterner; Prütz Karl-Göran; Naomi Clyne; Martin Almquist
Journal:  World J Surg       Date:  2017-09       Impact factor: 3.352

8.  Use of intraoperative parathyroid hormone measurements during parathyroidectomy to predict postoperative parathyroid hormone levels in patients with renal hyperparathyroidism: meta-analysis.

Authors:  Dirk-Jan van Beek; Stina Fredriksson; Stefanie Haegele; Marco Raffaelli; Philipp Riss; Martin Almquist
Journal:  BJS Open       Date:  2022-01-06

9.  Vitamin D Analogues and Fracture Risk in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Nada Khelifi; Louis-Charles Desbiens; Aboubacar Sidibé; Fabrice Mac-Way
Journal:  JBMR Plus       Date:  2022-02-21

10.  Impact of mineral and bone disorder on healthcare resource use and associated costs in the European Fresenius medical care dialysis population: a retrospective cohort study.

Authors:  Silvia Chiroli; Caroline Mattin; Vasily Belozeroff; Louise Perrault; Dominic Mitchell; Ioanna Gioni
Journal:  BMC Nephrol       Date:  2012-10-29       Impact factor: 2.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.